160 related articles for article (PubMed ID: 18072088)
1. Expression of activity-dependent neuroprotective protein in the brain of adult rats.
Gennet N; Herden C; Bubb VJ; Quinn JP; Kipar A
Histol Histopathol; 2008 Mar; 23(3):309-17. PubMed ID: 18072088
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes.
Furman S; Steingart RA; Mandel S; Hauser JM; Brenneman DE; Gozes I
Neuron Glia Biol; 2004 Aug; 1(3):193-9. PubMed ID: 16845437
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) co-localizes with activity-dependent neuroprotective protein (ADNP) in the mouse brains.
Nakamachi T; Ohtaki H; Yofu S; Dohi K; Watanabe J; Hayashi D; Matsuno R; Nonaka N; Itabashi K; Shioda S
Regul Pept; 2008 Jan; 145(1-3):88-95. PubMed ID: 17942168
[TBL] [Abstract][Full Text] [Related]
4. Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus.
Furman S; Hill JM; Vulih I; Zaltzman R; Hauser JM; Brenneman DE; Gozes I
Neurosci Lett; 2005 Jan; 373(1):73-8. PubMed ID: 15555780
[TBL] [Abstract][Full Text] [Related]
5. A novel VIP responsive gene. Activity dependent neuroprotective protein.
Gozes I; Zamostiano R; Pinhasov A; Bassan M; Giladi E; Steingart RA; Brenneman DE
Ann N Y Acad Sci; 2000; 921():115-8. PubMed ID: 11193814
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
Zusev M; Gozes I
Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
[TBL] [Abstract][Full Text] [Related]
8. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
Ivashko-Pachima Y; Gozes I
Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
[TBL] [Abstract][Full Text] [Related]
9. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
[TBL] [Abstract][Full Text] [Related]
10. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.
Oz S; Kapitansky O; Ivashco-Pachima Y; Malishkevich A; Giladi E; Skalka N; Rosin-Arbesfeld R; Mittelman L; Segev O; Hirsch JA; Gozes I
Mol Psychiatry; 2014 Oct; 19(10):1115-24. PubMed ID: 25178163
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.
Giladi E; Hill JM; Dresner E; Stack CM; Gozes I
J Mol Neurosci; 2007; 33(3):278-83. PubMed ID: 17952637
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease.
Chu Y; Morfini GA; Kordower JH
J Parkinsons Dis; 2016; 6(1):77-97. PubMed ID: 27003787
[TBL] [Abstract][Full Text] [Related]
13. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.
Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM
Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro ketamine exposure exhibits a dose-dependent induction of activity-dependent neuroprotective protein in rat neurons.
Brown BP; Kang SC; Gawelek K; Zacharias RA; Anderson SR; Turner CP; Morris JK
Neuroscience; 2015 Apr; 290():31-40. PubMed ID: 25595994
[TBL] [Abstract][Full Text] [Related]
15. Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease.
Gozes I
J Neurosci Res; 2017 Jan; 95(1-2):652-660. PubMed ID: 27870441
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.
Dresner E; Agam G; Gozes I
Eur Neuropsychopharmacol; 2011 May; 21(5):355-61. PubMed ID: 20598862
[TBL] [Abstract][Full Text] [Related]
17. From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.
Gozes I; Divinsky I; Pilzer I; Fridkin M; Brenneman DE; Spier AD
J Mol Neurosci; 2003; 20(3):315-22. PubMed ID: 14501014
[TBL] [Abstract][Full Text] [Related]
18. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
Gozes I
Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
[TBL] [Abstract][Full Text] [Related]
19. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol.
Pascual M; Guerri C
J Neurochem; 2007 Oct; 103(2):557-68. PubMed ID: 17623041
[TBL] [Abstract][Full Text] [Related]
20. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
